Rare coexistence of EGFR and KRAS mutations have been found in same tumors indicating that at functional level both the mutations have comparable impact in tumor progression.23, 30, 31, 32 These mutations have a very little prognostic significance. The gene discussed is KRAS; the disease is neoplasm.